BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 23406689)

  • 1. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions.
    Mori M; Hebson C; Shioda K; Elder RW; Kogon BE; Rodriguez FH; Jokhadar M; Book WM
    Congenit Heart Dis; 2016 Dec; 11(6):589-597. PubMed ID: 26932151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after transplantation for "failed" Fontan: a single-institution experience.
    Davies RR; Sorabella RA; Yang J; Mosca RS; Chen JM; Quaegebeur JM
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1183-1192.e4. PubMed ID: 22500594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
    Konno R; Tatebe S; Sugimura K; Satoh K; Aoki T; Miura M; Suzuki H; Yamamoto S; Sato H; Terui Y; Miyata S; Adachi O; Kimura M; Saiki Y; Shimokawa H
    PLoS One; 2019; 14(11):e0225403. PubMed ID: 31743362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients.
    Diller GP; Giardini A; Dimopoulos K; Gargiulo G; Müller J; Derrick G; Giannakoulas G; Khambadkone S; Lammers AE; Picchio FM; Gatzoulis MA; Hager A
    Eur Heart J; 2010 Dec; 31(24):3073-83. PubMed ID: 20929979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation.
    Amdani S; Boyle GJ; Cantor RS; Conway J; Godown J; Kirklin JK; Koehl D; Lal AK; Law Y; Lorts A; Rosenthal DN
    J Heart Lung Transplant; 2021 Dec; 40(12):1614-1624. PubMed ID: 34598872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
    Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
    ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-Stage Liver Disease Excluding INR (MELD-XI) score is associated with hemodynamic impairment and predicts mortality in critically ill patients.
    Wernly B; Lichtenauer M; Vellinga N; Boerma C; Ince C; Kelm M; Jung C
    Eur J Intern Med; 2018 May; 51():80-84. PubMed ID: 29572092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Body Mass Index Is Associated with Congestive Heart Failure and Mortality in Adult Fontan Patients.
    Martinez SC; Byku M; Novak EL; Cedars AM; Eghtesady P; Ludbrook PA; Billadello JJ
    Congenit Heart Dis; 2016; 11(1):71-9. PubMed ID: 26365670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is heart transplantation for complex congenital heart disease a good option? A 25-year single centre experience.
    Seddio F; Gorislavets N; Iacovoni A; Cugola D; Fontana A; Galletti L; Terzi A; Ferrazzi P
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):605-11; discussion 611. PubMed ID: 22733841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    Amdani S; Simpson KE; Thrush P; Shih R; Simmonds J; Knecht K; Mogul DB; Hurley K; Koehl D; Cantor R; Naftel D; Kirklin JK; Daly KP
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1462-1473.e12. PubMed ID: 33745714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the model for end-stage liver disease score for guiding clinical decision-making in the selection of patients for emergency cardiac transplantation.
    Vanhuyse F; Maureira P; Mattei MF; Laurent N; Folliguet T; Villemot JP
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):134-8. PubMed ID: 23345182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite risk factors predict survival after transplantation for congenital heart disease.
    Kavarana MN; Savage A; O'Connell R; Rubinstein CS; Flynn-Reeves J; Joshi K; Stroud MR; Ikonomidis JS; Bradley SM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):888-93. PubMed ID: 23886031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modern Fontan operation shows no increase in mortality out to 20 years: a new paradigm.
    Dabal RJ; Kirklin JK; Kukreja M; Brown RN; Cleveland DC; Eddins MC; Lau Y
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2517-23.e1. PubMed ID: 25277471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than the heart: Hepatic, renal, and cardiac dysfunction in adult Fontan patients.
    Byrne RD; Weingarten AJ; Clark DE; Huang S; Perri RE; Scanga AE; Menachem JN; Markham LW; Frischhertz BP
    Congenit Heart Dis; 2019 Sep; 14(5):765-771. PubMed ID: 31282062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients.
    Voeller RK; Epstein DJ; Guthrie TJ; Gandhi SK; Canter CE; Huddleston CB
    Ann Thorac Surg; 2012 Sep; 94(3):807-15; discussion 815-6. PubMed ID: 22632881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery.
    Fernandes SM; Alexander ME; Graham DA; Khairy P; Clair M; Rodriguez E; Pearson DD; Landzberg MJ; Rhodes J
    Congenit Heart Dis; 2011; 6(4):294-303. PubMed ID: 21418537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study.
    Schwartz MC; Sullivan L; Cohen MS; Russo P; John AS; Guo R; Guttenberg M; Rand EB
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):904-9. PubMed ID: 21955477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.